Siobhan Gaynor (Programme Manager- Clinical and Translational Research)
Susan Lennon (Clinical Research Manager)
Dr. Suzanne Bracken (Programme Officer- Translational Research)
Fionnuala Gibbons (Clinical Trials Liaison Officer)
Siobhan's role as Programme Manager –Clinical and Translational Research is to facilitate clinical investigators in conducting multi-centre clinical studies at a national and European level, to position ICRIN as the national coordinating body for clinical research in Ireland and to build capacity for translational research through collaborative initiatives in relation to biomarker discovery and validation, research technologies, biobanking and other relevant activities. In addition to her responsibility for directly managed resources, Siobhan works with clinical and translational personnel in the MMI partner institutions to maximise the return from the commitment to collaboration represented by MMI.
Siobhan joined ICRIN/Molecular Medicine Ireland from the all-Ireland Cooperative Oncology Research Group (ICORG) where she was Quality and Training Manager. ICORG is the Cancer disease network in Ireland. Siobhan has over 18 years experience in clinical trials, in industry, academia and in the contract research sector.
Siobhan is an experienced Good Clinical Practice trainer and auditor and has experience of monitoring and managing multinational trials in a number of disease areas. Siobhan has also worked as a research pharmacologist in the UK for a multinational pharmaceutical company.
Siobhan is a graduate of Trinity College Dublin and has a degree in Physiology.
Susan Lennon has over 20 years experience in the pharmaceutical industry and, in particular, in the implementation of clinical trials within contract research organisations (CROs).
Susan has also held a number of senior positions in customer relationship management, negotiating with both customers and internally on behalf of the customer to enable the timely delivery of high quality clinical trials. Susan holds a Masters in Biotechnology, a BSc in Microbiology/Biochemistry and a Diploma in Computers and in Management, all from UCC. Susan held roles initially in a veterinary pharmaceutical company within the areas of clinical trial design and regulatory affairs. She then moved to the CRO industry where she worked in the management of data management and laterally as European Head of Pharmacovigilance with responsibility for the implementation of the Clinical Trial Directive and electronic reporting.
Dr Suzanne Bracken is the Programme Officer for Translational Research at Molecular Medicine Ireland (MMI) where her responsibilities are to develop and deliver the work programme for translational research, as part of the ICRIN (Irish Clinical Research Infrastructure Network) team. Activities include the coordination of the Irish Biomarker Network and the MMI Biobanking Group.
Back to top
Fionnuala is the Clinical Trial Liaison Officer, within the Irish Clinical Research Infrastructure Network (ICRIN), which is hosted by Molecular Medicine Ireland (MMI). Fionnuala is responsible for the development of clinical research process knowledge and awareness among indigenous and multi-national pharmaceutical, medical device and biotechnology companies. This post is being funded by Enterprise Ireland .
Fionnuala has a wealth of experience in clinical research across the pharmaceutical industry. She initially began her career as a nurse, finishing as a theatre and anaesthetic sister in Charing Cross Hospital, London, and then transitioned to clinical research working as a Research Coordinator in the Thrombosis Research Centre in Kings College Hospital, Clinical Research Associate in PPD Contract Research Organisation in Cambridge and Senior Clinical Monitor/Project Manager in Bristol-Myers Squibb (BMS), Dublin. Fionnuala has worked across a variety of therapeutic areas including cardiology, oncology, haematology, rheumatology, endocrinology, psychiatry, CNS and HIV. Prior to joining MMI, Fionnuala held the position of Oncology Scientific Advisor for sanofi-aventis.